![](https://i0.wp.com/glhf.org/wp-content/uploads/2019/07/Bayer-Re-Sizecd.jpg?resize=668%2C335&ssl=1)
New Article Offers Scientific Overview of AAV Vectors and Hemophilia Gene Therapy
Read about some of the primary considerations relevant to investigational hemophilia gene therapies that employ adeno-associated viral (AAV) vectors.
Source: National Hemophilia Foundation